Scientific presentations and workshops to highlight two day event
NEW HAVEN, Conn., Oct. 6 /PRNewswire/ -- The StemCONN 09 stem cell symposium will bring the stem cell research community to New Haven, Conn., March 23 - 24, 2009.
Building on the successful StemCONN 07, which brought 700 scientists, business leaders and students to Hartford last year, StemCONN 09 will showcase the latest advances in stem cell research and their potential medical applications. Included in the two day event are scientific presentations by leading authorities, as well as sessions on the translation of scientific research to the clinic, emerging technologies and bioethics.
StemCONN 09 will include:
-- A scientific session featuring presentations by Kevin Eggan Ph.D. and
Konrad Hochedlinger Ph.D., both of Harvard University; Craig T. Jordan
Ph.D., University of Rochester; Thomas A. Rando M.D., Ph.D., of Stanford
University; Celeste Simon Ph.D., University of Pennsylvania, and Sally
Temple Ph.D., Albany Medical Center.
-- A session on bioethics organized by Lori Gruen Ph.D., of Wesleyan
University in collaboration with Anne Hiskes Ph.D., of the University of
-- A session on "Translation to Clinic" that will look at the
opportunities and barriers to converting stem cell research to therapies
as well as promising options for using stem cells for drug discovery.
With its 10-year, $100 million stem cell research grant program, Connecticut has emerged as an innovative leader in the field of stem cell research. The state is home to leading academic institutions specializing in this area, including Yale University, the University of Connecticut and Wesleyan University, providing a culture where national and international stem cell research partnerships develop, thrive and grow.
Organizing StemCONN 09 are Yale University, Wesleyan Univers
|SOURCE CURE (Connecticut United for Research Excellence)|
Copyright©2008 PR Newswire.
All rights reserved